For the third year in a row, an investor is proposing that the pharmaceutical company scrap the tradition of combining the role of chief executive officer and board chair.
Additionally, the pharmaceutical giant said in a statement that it had “suspended all investments, promotional activities, and new clinical trials in Russia.”
Indiana-based firms are struggling with how to protect their employees and their business interests in those countries while also condemning the Russian government’s actions.
While we’ll all likely be grumbling about high gasoline prices for some time to come, President Joe Biden’s decision this week to ban Russian oil imports was unquestionably the right move.
Nearly 30 million Americans have diabetes, and more than 6 million use insulin to keep their blood sugars under control. It’s an old drug, refined over the years, that has seen relentless price increases.
Elanco Animal Health Inc. said Thursday morning that revenue climbed 46% last year and its net loss narrowed, strengthening its financial position as it prepares to break ground this spring on a new $100 million headquarters in Indianapolis.
The Indianapolis-based pharmaceutical company said the facility is part of its strategy to advance RNA-based therapeutics and builds on its acquisition of Prevail Therapeutics, a gene therapy company based in New York.
The Indianapolis-based drugmaker said the antibody is effective against the omicron variant and it has already manufactured several hundred thousand doses. The deal calls for the federal government to pay Lilly more than $720 million.
More investigative and enterprise journalism is on the list of what we’d like to do more of this year, and we are strategizing ways to make that happen without sacrificing the daily news you expect from us.
The FDA has agreed to speed up review of donanemab, but the Centers for Medicare and Medicaid Services is moving to limit reimbursement for drugs in this class to only patients in clinical trials.
The disclosure of the group’s composition is the first since the mall opened in 1995, and comes about one week after Circle Centre Development acknowledged Simon Property Group’s exit.
The deal calls for the federal government to pay Eli Lilly and Co. more than $720 million for the antibody, which the company said is effective against all COVID-19 variants.
Lisa Schlehuber has served as CEO of Indianapolis-based Elements Financial since 2005. She’ll retire from the role in April, the credit union announced Wednesday.
Despite Indiana’s economic development successes, industry experts say the state must do more to attract multibillion-dollar megadeals like ones other states have recently landed.
In December, the U.S. government paused distribution of Lilly’s two previous antibodies, saying they did not appear effective against the omicron variant.
Four of the five research studies that received the most National Institutes of Health funding at the school were for Alzheimer’s disease research, one of the school’s top research priorities.
Lilly said it selected Concord, North Carolina, because of the manufacturing technology experience of the local labor force; its proximity to universities with strong science, technology, engineering and math programs; and its access to major transportation infrastructure.
Indianapolis-based Eli Lilly and Co., one of three primary U.S. insulin manufacturers, said it was “deeply disappointed by the false accusations and inaccurate claims” made by the attorney general.
